SARS-CoV-2 感染会加剧纤维化,并在受多甲基胺酸损坏的肺部中发展出新发喘
Seulgi Jeon1, Young Kyu Kim2, Gyun-Baek Seo1
1Center for Respiratory Safety Research, Korea Institute of Toxicology, Jeongeup-si, Jeonbuk-do 56212, Republic of Korea.
Journal of hazardous materials
|May 4, 2025
概括
聚甲基酸 (PHMG-p) 造成的化学肺损伤使SARS-CoV-2感染恶化,导致严重的炎症和潜在的新发性喘. 这凸显了疫情期间接触化学品的人群面临的风险.
科学领域:
- 环境健康 环境健康
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
背景情况:
- 现代社会面临着由化学物质暴露和传染病引起的呼吸系统威胁日益增加.
- 化学诱导的肺损伤是呼吸道感染的重要危险因素.
- 化学肺损伤与SARS-CoV-2感染之间的相互作用仍未得到充分研究.
研究的目的:
- 调查聚甲基胺酸盐 (PHMG-p) 诱导的肺损伤对SARS-CoV-2感染严重性的影响.
- 为了确定共同感染的小鼠中加剧的呼吸道症状背后的分子机制.
- 探索化学肺损伤,SARS-CoV-2和喘发展之间的潜在联系.
主要方法:
- 使用了一种患有PHMG-p诱导肺损伤 (PILI) 的小鼠模型.
- 在PILI小鼠中评估了SARS-CoV-2感染症状和炎症反应.
- 进行了支气管支气管洗液分析和RNA-sequencing (RNA-seq) 用于基因表达造型.
主要成果:
- 皮利小鼠在感染SARS-CoV-2时表现出严重的肺损伤和高度的炎症反应.
- 在感染PILI小鼠中观察到高的细胞因子风暴标志物.
- RNA-seq揭示了与呼吸系统疾病和炎症相关的上调基因,以及参与脂质代谢的下调基因.
- 在感染PILI小鼠中,发现了四个喘相关基因的变异.
结论:
- SARS-CoV-2 感染会加剧化学损伤肺部的肺损伤和炎症.
- 化学肺损伤可能会增加对严重感染的易感性,并可能引发新发喘.
- 对暴露在化学物质中的个人来说,提高呼吸系统健康意识至关重要,特别是在传染病爆发期间.
相关概念视频
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management
225
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
225
Asthma-III: Symptoms and Complications
2.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.4K
Other Pulmonary Disorders
782
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
782


